Abstract:This corrects the article ?Computer-aided approach for the identification of lead molecules as the inhibitors of cholinesterase?s and monoamine oxidases: Novel target for the treatment of Alzheimer disease? published in volume 89, number 2, page 117 (https://doi.org/10.2298/JSC230307050E). CONTENT OF THE CORRECTION For author Ammara Fayyaz, additional affiliation is added. Previous affiliation was: 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan Corrected affiliation for Ammara Fayyaz: 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan, 4School of Pharmaceutical Science and Technology, Tianjin University, 30072, Tianjin, China In Acknowledgement, the previous supporting project number was RSP-2023/357. Correct acknowledgement is: The authors extend their appreciation to researchers supporting project number RSP2024R357, King Saud University, Riyadh, Saudi Arabia, for funding this research. Link to the corrected article 10.2298/JSC230307050E

Correction to “Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II – Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertensin”

Correction: Aliskiren Therapy in Hypertension and Cardiovascular Disease: a Systematic Review and a Meta-Analysis

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Corrigendum to: Chloro-s-triazenes-toxicokinetic, Toxicodynamic, Human Exposure, and Regulatory Considerations

Error in Author Name, Figure 3A and C, and Table 1

Corrigendum to “knockdown of Herp Alleviates Hyperhomocysteinemia Mediated Atherosclerosis Through the Inhibition of Vascular Smooth Muscle Cell Phenotype Switching” [int. J. Cardiol. 269 (2018) 242–249]

Correction to "Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs"

Erratum: Correction of author’s affiliation and acknowledgement in the article: Computer-aided approach for the identification of lead molecules as the inhibitors of cholinesterase’s and monoamine oxidases: Novel target for the treatment of Alzheimer disease

Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells

Correction: Angioarchitectural alterations in the retina and choroid in frontotemporal dementia

Corrigendum to: Association between ABCC8 Ala1369Ser Polymorphism (rs757110 T/G) and Type 2 Diabetes Risk in an Iranian Population: A Case-Control Study

Correction to [Anti-PL-12 anti-synthetase syndrome manifesting with multiple digital ischemia: Case report & review of the literature]

Corrigendum to: Progress of Angiogenesis Signal Pathway and Antiangiogenic Drugs in Nasopharyngeal Carcinoma

Erratum: Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review: Erratum

Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension: Erratum

Correction: The longitudinal association between patient empowerment and patient-reported outcomes: What is the direction of effect?

Correction to: Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019

Correction To: Central Blockade of E-Prostanoid 3 Receptor Ameliorated Hypertension Partially by Attenuating Oxidative Stress and Inflammation in the Hypothalamic Paraventricular Nucleus of Spontaneously Hypertensive Rats

Error in Byline and Affiliations